Sector: Healthcare|Industry: Diagnostics & Research|Market Cap: $200.81B|Employees: 122K
Thermo Fisher Scientific Inc. is the world leader in serving science, providing a combination of innovative technologies, purchasing convenience, and pharmaceutical services. The company's core business model revolves around providing products and services to customers in pharmaceutical, biotech, academic, government, and industrial markets. They have a global presence with a focus on enabling customers to make the world healthier, cleaner and safer.
The company's revenue decreased to $42.857 billion in 2023 from $44.915 billion in 2022, a 5% decline. This decrease is primarily due to reduced demand for COVID-19 related products.
GAAP operating income margin decreased to 16.0% in 2023 from 18.7% in 2022. This decline is primarily due to lower COVID-19 related revenue, partially offset by productivity improvements.
Adjusted earnings per share decreased to $21.55 in 2023 from $23.24 in 2022. This decline reflects the decrease in revenue and operating income.